药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Paricalcitol
Azilsartan medoxomil
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Azilsartan medoxomil is combined with Aminophenazone.
Paricalcitol
Saralasin
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Saralasin is combined with Aminophenazone.
Paricalcitol
Tasosartan
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Tasosartan is combined with Aminophenazone.
Paricalcitol
Saprisartan
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Saprisartan is combined with Aminophenazone.
Paricalcitol
Forasartan
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Forasartan is combined with Aminophenazone.
Paricalcitol
Irbesartan
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Irbesartan is combined with Aminophenazone.
Paricalcitol
Cyproterone acetate
The metabolism of Aminophenazone can be increased when combined with Cyproterone acetate.
Paricalcitol
Edetic acid
The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Edetic acid.
Paricalcitol
Troxerutin
The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Troxerutin.
Paricalcitol
Reviparin
The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Reviparin.
Paricalcitol
Dabigatran
The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Dabigatran.
Paricalcitol
Edetate calcium disodium anhydrous
The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Edetate calcium disodium anhydrous.
Paricalcitol
Tocopherylquinone
The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Tocopherylquinone.
Paricalcitol
(S)-Warfarin
The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with (S)-Warfarin.
Paricalcitol
Saruplase
The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Saruplase.
Paricalcitol
Melagatran
The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Melagatran.
Paricalcitol
Tioclomarol
The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Tioclomarol.
Paricalcitol
Diphenadione
The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Diphenadione.
Paricalcitol
Clorindione
The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Clorindione.
Paricalcitol
Brinase
The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Brinase.